rs147131452
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2
The NM_020451.3(SELENON):c.1645G>A(p.Val549Met) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0013 in 1,614,140 control chromosomes in the GnomAD database, including 14 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/18 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Consequence
NM_020451.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -20 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
SELENON | NM_020451.3 | c.1645G>A | p.Val549Met | missense_variant | 13/13 | ENST00000361547.7 | |
SELENON | NM_206926.2 | c.1543G>A | p.Val515Met | missense_variant | 12/12 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
SELENON | ENST00000361547.7 | c.1645G>A | p.Val549Met | missense_variant | 13/13 | 1 | NM_020451.3 | ||
SELENON | ENST00000374315.1 | c.1543G>A | p.Val515Met | missense_variant | 12/12 | 5 | P1 | ||
SELENON | ENST00000354177.9 | c.1474G>A | p.Val492Met | missense_variant | 12/12 | 5 | |||
SELENON | ENST00000494537.2 | c.*165G>A | 3_prime_UTR_variant, NMD_transcript_variant | 13/13 | 3 |
Frequencies
GnomAD3 genomes AF: 0.00265 AC: 403AN: 152160Hom.: 2 Cov.: 33
GnomAD3 exomes AF: 0.00272 AC: 679AN: 249548Hom.: 5 AF XY: 0.00284 AC XY: 384AN XY: 135394
GnomAD4 exome AF: 0.00116 AC: 1689AN: 1461862Hom.: 12 Cov.: 31 AF XY: 0.00124 AC XY: 905AN XY: 727238
GnomAD4 genome AF: 0.00267 AC: 406AN: 152278Hom.: 2 Cov.: 33 AF XY: 0.00263 AC XY: 196AN XY: 74466
ClinVar
Submissions by phenotype
not provided Benign:3
Benign, criteria provided, single submitter | clinical testing | GeneDx | Jul 25, 2019 | This variant is associated with the following publications: (PMID: 22426012) - |
Likely benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Likely benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Aug 01, 2024 | SELENON: BP4, BS1 - |
not specified Benign:2
Likely benign, criteria provided, single submitter | clinical testing | Athena Diagnostics | Jun 01, 2017 | - - |
Likely benign, criteria provided, single submitter | clinical testing | PreventionGenetics, part of Exact Sciences | - | - - |
SEPN1-related disorder Benign:1
Benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jan 12, 2018 | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. - |
Eichsfeld type congenital muscular dystrophy Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 26, 2024 | - - |
Eichsfeld type congenital muscular dystrophy;C0546264:Congenital myopathy with fiber type disproportion Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | Feb 15, 2022 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at